On July 1, 2020 Physicians’ Education Resource, LLC (PER), reported that Heather A. Wakelee, M.D., professor of oncology at Stanford Medicine in California, will join the prestigious panel of program co-chairs at the 21st Annual International Lung Cancer Congress (Press release, Physicians’ Education Resource, JUL 1, 2020, View Source [SID1234561628]). The conference will take place July 23-25 as a live, interactive CME-certified virtual webcast.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The other co-chairs leading the 2020 congress are:
David R. Gandara, M.D., professor of medicine, division of hematology/oncology, UC Davis School of Medicine, Sacramento, California; director of the thoracic oncology program and senior adviser to director, UC Davis Comprehensive Cancer Center.
Roy S. Herbst, M.D., Ph.D., ensign professor of medical oncology, professor of pharmacology; chief of medical oncology, Yale Cancer Center’s Smilow Cancer Hospital in New Haven, Connecticut; associate cancer director for translational research, Yale Cancer Center.
"We are eager to have Dr. Wakelee join the leadership team for our upcoming comprehensive expert-developed lung cancer program this July," said Phil Talamo, president of PER. "As the leading go-to resource for continuing medical education, we are proud to work with such renowned in the field and look forward to the powerhouse panel of co-chairs to discuss the most relevant and impactful strategies in the treatment and management of lung cancers."
For 21 years, the International Lung Cancer Congress has brought together medical, surgical and radiation oncologists to foster awareness of state-of-the-art treatments for patients with lung cancer. During this two-day webcast, leading international and national experts will provide perspectives on how to apply the latest data on targeted agents, immunotherapy, surgery and radiation oncology in the clinic. Cutting-edge lectures, panel discussions, multidisciplinary tumor boards and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with the faculty as they share their perspectives and personal experiences on the clinical challenges and ongoing controversies in lung cancer management.
Dr. Wakelee added, "The ILCC has played a central role in my career development since my first conference participation in 2002 when I was an oncology fellow. I have never missed a meeting and am delighted to now step into a leadership role along with Drs. Gandara and Herbst."
Accredited by the Accreditation Council for Continuing Medical Education and approved by the California Board of Registered Nursing, this live webcast will provide participants with the opportunity to earn up to 20.5 AMA PRA Category 1 Credits and 20.5 nursing contact hours.